“…In vivo experiments showed that CYP2J2 overexpression attenuates production of VCAM, E-selectin, IL-1  , and IL-6 while enhancing production of the anti-infl ammatory cytokine IL-10. In addition, CYP2J2 gene delivery via intravenous injection signifi cantly increased CYP2J2 expression in vivo in most organs, mainly aorta, heart, liver, and kidney ( 3,5,6,36,37 ), which may also explain some effects of heart protection. These results support the view that CYP2J2-derived EETs protect the heart via their antiinfl ammatory, antiapoptotic, and prosurvival effects.…”